Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Fri, 18 Aug 17 14:23:51 +0000 Fri, 18 Aug 17 14:23:51 +0000 Government Scrutiny and Qui Tams http://www.pharmacytimes.com/news/government-scrutiny-and-qui-tams http://www.pharmacytimes.com/news/government-scrutiny-and-qui-tams The US Department of Justice (&ldquo;DOJ&rdquo;) and the Office of Inspector General (&ldquo;OIG&rdquo;) have become much more aggressive in bringing civil and criminal investigations against pharmacies and their owners. Fri, 18 Aug 17 12:30:00 +0000 Using the Patient Care Process in the Community: Patient-Oriented Care http://www.pharmacytimes.com/news/using-the-patient-care-process-in-the-community-patientoriented-care http://www.pharmacytimes.com/news/using-the-patient-care-process-in-the-community-patientoriented-care Community pharmacists are valuable health care providers given their accessibility and distribution throughout the community, extended hours of operation, and clinical knowledge. Thu, 17 Aug 17 12:30:00 +0000 Cannabis for Patients with Chronic Pain, PTSD: More Evidence Needed http://www.pharmacytimes.com/news/cannabis-for-patients-with-chronic-pain-ptsd-more-evidence-needed http://www.pharmacytimes.com/news/cannabis-for-patients-with-chronic-pain-ptsd-more-evidence-needed Researchers continue to search for evidence regarding the use of cannabis for medicinal purposes. Thu, 17 Aug 17 12:00:00 +0000 2015-2016 Influenza Season: Live Attenuated Vaccine Ineffective http://www.pharmacytimes.com/news/20152016-influenza-season-live-attenuated-vaccine-ineffective http://www.pharmacytimes.com/news/20152016-influenza-season-live-attenuated-vaccine-ineffective During the 2015-2016 season, influenza vaccines overall reduced the risk of influenza illness, but the live attenuated influenza vaccine (LAIV) was ineffective in children, according to a recently-published study. Wed, 16 Aug 17 13:41:00 +0000 Anxiety Medication Recalled Due to Dosing Dropper Defect http://www.pharmacytimes.com/news/anxiety-medication-recalled-due-to-dosing-dropper-defect http://www.pharmacytimes.com/news/anxiety-medication-recalled-due-to-dosing-dropper-defect Amneal Pharmaceuticals has issued a voluntary nationwide recall of its Lorazepam Oral Concentrate, USP 2mg/mL, due to a defect in the dropper markings that are supplied with the product, according to a company press release. Wed, 16 Aug 17 13:37:00 +0000 NASP Launches Website to Educate About DIR Fees http://www.pharmacytimes.com/news/nasp-launches-website-to-educate-about-dir-fees http://www.pharmacytimes.com/news/nasp-launches-website-to-educate-about-dir-fees StopDIRfees.com features materials and resources to educate patients, providers, legislators, government administrators, industry analysts, media, and taxpayers about DIR fees, according to the release. Wed, 16 Aug 17 05:30:00 +0000 Case Study: A Pharmacist-Parent Eyes the Zebra Side Effect in a Field Full of Horses http://www.pharmacytimes.com/news/eyeing-the-zebra-side-effect-in-a-field-full-of-horses http://www.pharmacytimes.com/news/eyeing-the-zebra-side-effect-in-a-field-full-of-horses How a mother&#39;s intutition, and a pharmacy background, proved important in identifying a medication-related side effect.&nbsp; Mon, 14 Aug 17 05:15:00 +0000 4 New FDA Approvals to Know from July 2017 http://www.pharmacytimes.com/news/4-new-fda-approvals-to-know-from-july-2017 http://www.pharmacytimes.com/news/4-new-fda-approvals-to-know-from-july-2017 Learn about the new products and expanded indications approved by the FDA in July 2017. Fri, 11 Aug 17 13:00:00 +0000 Study: Closthioamide for Gonorrhea? http://www.pharmacytimes.com/news/study-closthioamide-for-gonorrhea http://www.pharmacytimes.com/news/study-closthioamide-for-gonorrhea Researchers have found a new antibiotic that may have the potential to treat gonorrhea, according to a study published recently in <em>Antimicrobial Agents and Chemotherapy</em>. Thu, 10 Aug 17 12:00:00 +0000 FDA Alert: Liquid Drug Products Contaminated with Burkholderia Cepacia http://www.pharmacytimes.com/product-news/fda-alert-liquid-drug-products-contaminated-with-burkholderia-cepacia http://www.pharmacytimes.com/product-news/fda-alert-liquid-drug-products-contaminated-with-burkholderia-cepacia Officials with the FDA are warning health care professionals and patients not to use any liquid product manufactured by PharmaTech LLC, Davie, Florida, due to possible<em> Burkholderia cepacia</em> contamination, according to a safety alert issued by the FDA. Wed, 09 Aug 17 14:39:00 +0000 Lead Poisoning Risk Linked with Balguti Kesaria http://www.pharmacytimes.com/product-news/lead-poisoning-risk-linked-with-balguti-kesaria http://www.pharmacytimes.com/product-news/lead-poisoning-risk-linked-with-balguti-kesaria Officials with the FDA have issued a safety alert warning against the use of &ldquo;Balguti Kesaria (or Kesaria Balguti) Ayurvedic Medicine,&rdquo; due to high levels of lead. Tue, 08 Aug 17 17:41:00 +0000 Risks When Marketing http://www.pharmacytimes.com/news/risks-when-marketing http://www.pharmacytimes.com/news/risks-when-marketing The anti-kickback statute makes it a felony to knowingly and willfully offer, pay, solicit, or receive any remuneration to induce a person (including a legal entity) to refer an individual for the furnishing or arranging for the furnishing of any Medicare-covered item or service. Tue, 08 Aug 17 15:31:00 +0000 Fungal Disease Awareness Week: CDC Wants You to 'Think Fungus' http://www.pharmacytimes.com/news/fungal-disease-awareness-week-cdc-wants-you-to-think-fungus- http://www.pharmacytimes.com/news/fungal-disease-awareness-week-cdc-wants-you-to-think-fungus- Video series encourages patients to &quot;think fungus&quot; if symptoms don&#39;t improve.&nbsp; Mon, 07 Aug 17 18:39:00 +0000 Judge Issues Injunction Against Pharmacy Company http://www.pharmacytimes.com/news/judge-issues-injunction-against-pharmacy-company- http://www.pharmacytimes.com/news/judge-issues-injunction-against-pharmacy-company- Isomeric allegedly manufactured and distributed purportedly sterile drug products, including injectable and ophthalmic drugs that were adulterated because the drugs were made under insanitary conditions. Fri, 04 Aug 17 19:12:00 +0000 DEA Proposes Reducing Opioid Manufacturing for 2018 http://www.pharmacytimes.com/news/dea-proposes-reducing-opioid-manufacturing-for-2018 http://www.pharmacytimes.com/news/dea-proposes-reducing-opioid-manufacturing-for-2018 Officials with the US Drug Enforcement Administration (DEA) have proposed to cut the amount of controlled substances to be manufactured in 2018 by 20%, compared to 2017,&nbsp;according to a press release. Fri, 04 Aug 17 18:14:00 +0000 Program Targets Opioid Fraud and Abuse http://www.pharmacytimes.com/news/program-targets-opioid-fraud-and-abuse http://www.pharmacytimes.com/news/program-targets-opioid-fraud-and-abuse To combat the abuse and diversion of opioid medications, Attorney General Jeff Sessions has announced the formation of a new Department of Justice (DOJ) pilot program to crack down on opioid-related health care fraud. Fri, 04 Aug 17 13:16:00 +0000 FDA Advisory Committee Does Not Recommend Sirukumab http://www.pharmacytimes.com/news/fda-advisory-committee-does-not-recommend-sirukumab- http://www.pharmacytimes.com/news/fda-advisory-committee-does-not-recommend-sirukumab- Although the FDA is not bound by the recommendation of the committee, their advice is taken into consideration.<br /> &nbsp; Fri, 04 Aug 17 01:23:00 +0000 FDA Approves Hepatitis C Drug http://www.pharmacytimes.com/product-news/fda-approves-hepatitis-c-drug http://www.pharmacytimes.com/product-news/fda-approves-hepatitis-c-drug Officials with the FDA have announced the approval of glecaprevir and pibrentasvir (Mavyret, AbbVie Inc) for hepatitis C.&nbsp; Thu, 03 Aug 17 20:40:00 +0000 FDA Approves Treatment for Acute Myeloid Leukemia http://www.pharmacytimes.com/news/fda-approves-treatment-for-acute-myeloid-leukemia http://www.pharmacytimes.com/news/fda-approves-treatment-for-acute-myeloid-leukemia The safety and efficacy of Vyxeos were studied in 309 patients with newly diagnosed t-AML or AML-MRC who were randomly assigned to receive Vyxeos or separately administered treatments of daunorubicin and cytarabine. Thu, 03 Aug 17 14:50:00 +0000 FDA Approves Chronic Graft Versus Host Disease Treatment http://www.pharmacytimes.com/news/fda-approves-chronic-graft-versus-host-disease-treatment http://www.pharmacytimes.com/news/fda-approves-chronic-graft-versus-host-disease-treatment The efficacy and safety of ibrutinib for the treatment of cGVHD were studied in a single-arm trial of 42 patients with cGVHD whose symptoms persisted despite standard treatment with corticosteroids. Wed, 02 Aug 17 19:43:00 +0000 First Oral Treatment for Relapsed, Refractory Acute Myeloid Leukemia Wins FDA Approval http://www.pharmacytimes.com/product-news/first-oral-treatment-for-relapsed-refractory-acute-myeloid-leukemia-wins-fda-approval http://www.pharmacytimes.com/product-news/first-oral-treatment-for-relapsed-refractory-acute-myeloid-leukemia-wins-fda-approval Officials with the FDA have approved enasidenib (Idhifa, Celgene Corporation) to treat adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation, isocitrate dehydrogenase-2 (IDH2), according to a FDA press release. Tue, 01 Aug 17 17:56:00 +0000 FDA Issues Safety Alert for Compounded Triamcinolone and Moxifloxacin Drug http://www.pharmacytimes.com/product-news/fda-issues-safety-alert-for-compounded-triamcinolone-and-moxifloxacin-drug http://www.pharmacytimes.com/product-news/fda-issues-safety-alert-for-compounded-triamcinolone-and-moxifloxacin-drug The FDA has issued a safety alert after receiving serious adverse events reports regarding intravitreal (eye) injections of a medication containing triamcinolone and moxifloxacin. Mon, 31 Jul 17 14:16:00 +0000 Dermatology Drug Manufacturer to Cease Distribution of Unapproved Products http://www.pharmacytimes.com/product-news/dermatology-drug-manufacturer-to-cease-distribution-of-unapproved-products http://www.pharmacytimes.com/product-news/dermatology-drug-manufacturer-to-cease-distribution-of-unapproved-products Tennessee drug company Crown Laboratories Inc. has agreed to cease the manufacturing and distribution of unapproved and misbranded dermatologic creams and lotions. Thu, 27 Jul 17 19:18:00 +0000 Pharmacist, Pharmacy Marketer Plead Guilty in Compound Medication Schemes http://www.pharmacytimes.com/news/pharmacist-pharmacy-marketer-plead-guilty-in-compound-medication-schemes http://www.pharmacytimes.com/news/pharmacist-pharmacy-marketer-plead-guilty-in-compound-medication-schemes A Mississippi pharmacist in charge of a compounding pharmacy pleaded guilty to his role in a $192 million compounded medication scheme, according to the Department of Justice (DOJ). Thu, 27 Jul 17 19:16:00 +0000 Pharmacists Rank on Glassdoor's Most Competitive In-Demand Jobs List http://www.pharmacytimes.com/news/pharmacists-rank-on-glassdoors-most-competitive-indemand-jobs-list http://www.pharmacytimes.com/news/pharmacists-rank-on-glassdoors-most-competitive-indemand-jobs-list Pharmacists continue to rank among best-paying professions, but competition in the job market is high. &nbsp; Thu, 27 Jul 17 16:11:00 +0000